Long-Term Efficacy and Safety of Linagliptin in Patients With Type 2 Diabetes and Severe Renal Impairment: A 1-year, randomized, double-blind, placebo-controlled study

OBJECTIVE: This placebo-controlled study assessed long-term efficacy and safety of the dipeptidyl peptidase-4 inhibitor linagliptin in patients with type 2 diabetes and severe renal impairment (RI). RESEARCH DESIGN AND METHODS: In this 1-year, double-blind study, 133 patients with type 2 diabetes (H...

詳細記述

保存先:
書誌詳細
主要な著者: McGill, Janet B., Sloan, Lance, Newman, Jennifer, Patel, Sanjay, Sauce, Christophe, von Eynatten, Maximilian, Woerle, Hans-Juergen
フォーマット: Artigo
言語:Inglês
出版事項: American Diabetes Association 2013
主題:
Original Research
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC3554278/
https://ncbi.nlm.nih.gov/pubmed/23033241
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc12-0706
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料